30M Genomics
PrivateLast Round
Seed
Dec 11, 2024
Total Funding Raised
$18,200
Company Overview
30M Genomics operates in Healthcare & Life Sciences and is based in Hyderabad. Its latest recorded funding round was a Grant round in March 2021.
30M Genomics is a genomics company that provides a rapid and low-cost technology for DNA sequencing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Medical AI, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
30M Genomics Comparables
Compare 30M Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GenePoweRx | 84% | |
| Clevergene | 77% | |
| Mapmygenome | 76% |
For institutional investors. Book with your work email.
30M Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 11, 2024 | ||||
| Grant | Mar 17, 2021 | ||||
| Accelerator | Jan 28, 2021 |
For institutional investors. Book with your work email.
30M Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vel Tech Technology Business Incubator | Grant |
| Biotechnology Industry Research Assistance Council | Seed |
| Atal Innovation Centre-Centre for Cellular and Molecular Biology | Grant |
| Department of Science & Technology | Grant |
| JioGenNext | Accelerator |
| Venture Center | Seed |
| Ministry of Electronics and Information Technology | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 25, 2026
Grew 38% QoQ from 8 to 11 employees.
- Apr 16, 2026
Monthly visitors increased 489% MoM, reaching 2.2K.
For institutional investors. Book with your work email.
30M Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about 30M Genomics's valuation, stock price, and market status.
Is 30M Genomics a public or private company?
30M Genomics is a private company.
What is the current stock price of 30M Genomics?
30M Genomics is a private company, so its shares have no public market price. Caplight tracks 30M Genomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is 30M Genomics worth (valuation)?
Valuation information for 30M Genomics is not publicly available.
Can I buy 30M Genomics stock?
30M Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was 30M Genomics's last funding round?
30M Genomics's most recent funding round was Seed on December 11, 2024.
Who are the main investors in 30M Genomics?
Key investors in 30M Genomics include Vel Tech Technology Business Incubator, Atal Innovation Centre-Centre for Cellular and Molecular Biology, JioGenNext, Venture Center.
Will 30M Genomics IPO soon?
No public IPO plans have been announced for 30M Genomics.
How can I track 30M Genomics secondary market activity?
Caplight tracks bids, offers, and trades in 30M Genomics's shares on secondary markets.